Nefopam is administered as a preemptive analgesic drug to the patient undergoing breast cancer surgery. It will be evaluated whether postoperative acute and chronic pain can be reduced.
Breast Neoplasm
Nefopam
Saline
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients diagnosed with breast cancer
Lumpectomy with axillary lymph node dissection or Lumpectomy with sentinel lymph node biopsy
American Society of Anesthesiologists physical status I or II